Lyudmila Burdelya, PhD, and Vadim Krivokrysenko, PhD, "Entolimod as a dual use oncology biodefense drug"
Organized by the UB Clinical and Translational Science Institute Drug Development Core, this series presents:
- Case studies in drug discovery and pre-clinical development
- Opportunities to become familiar with GLP and pre-clinical drug development programs
- Regulatory compliance leading to IND application
- Strategies for translation to Phase I study design
Kelly Patton, MSHA